AI Boosts Cancer Drug Trials
New research shows AI tools can greatly improve cancer drug studies, making them faster and cheaper.
Developing new cancer drugs costs a lot of money. It also takes a long time. A new report shows artificial intelligence, or AI, can change that. AI tools can make drug trials much more efficient. This helps bring new medicines to patients faster.
Researchers at Tufts University studied how AI helps in drug trials. They found AI tools save a lot of money. For every dollar spent on AI, companies could save up to $82. This big saving comes from using AI to watch over the trials. It helps catch problems early and keeps things on track.
AI acts like a smart helper. It monitors patient data during the trial. It spots trends and flags issues that human eyes might miss. This means trials run smoother. It also means less wasted time and resources.
These findings are important for drug makers. They can now see clear benefits from using AI. This speeds up the process of getting life-saving cancer treatments to those who need them. It offers hope for future medical breakthroughs.
Source: FierceBiotech
More from Biotech
